SIMILAR PATTERNS OF AMINO ACIDS FOR 2X0Y_A_X0TA1625
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ar1 | CYTOCHROME C OXIDASE (Paracoccusdenitrificans) |
PF00116(COX2)PF02790(COX2_TM) | 5 | ASP B 130VAL B 132TYR B 127VAL B 163VAL B 3 | None | 1.46A | 2x0yA-1ar1B:undetectable | 2x0yA-1ar1B:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wxx | HYPOTHETICAL PROTEINTTHA1280 (Thermusthermophilus) |
PF10672(Methyltrans_SAM) | 5 | VAL A 184TYR A 113VAL A 118VAL A 162ASP A 149 | None | 1.26A | 2x0yA-1wxxA:undetectable | 2x0yA-1wxxA:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2im9 | HYPOTHETICAL PROTEIN (Legionellapneumophila) |
PF07313(DUF1460) | 5 | ASP A 119VAL A 122ASN A 165VAL A 242ASP A 288 | None | 0.95A | 2x0yA-2im9A:undetectable | 2x0yA-2im9A:18.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iut | DNA TRANSLOCASE FTSK (Pseudomonasaeruginosa) |
PF01580(FtsK_SpoIIIE) | 5 | ASP A 498VAL A 476ASN A 477VAL A 701ASP A 698 | None | 1.46A | 2x0yA-2iutA:undetectable | 2x0yA-2iutA:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2j3h | NADP-DEPENDENTOXIDOREDUCTASE P1 (Arabidopsisthaliana) |
PF00107(ADH_zinc_N)PF16884(ADH_N_2) | 5 | ASP A 204VAL A 184TYR A 182THR A 158ASN A 244 | None | 1.24A | 2x0yA-2j3hA:undetectable | 2x0yA-2j3hA:20.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2j4g | HYALURONOGLUCOSAMINIDASE (Bacteroidesthetaiotaomicron) |
PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 7 | ASP A 242TYR A 282THR A 310VAL A 314ASN A 339VAL A 342ASP A 344 | NB1 A1590 (-3.7A)NB1 A1590 (-3.8A)NB1 A1590 (-3.9A)NoneNB1 A1590 (-3.6A)NB1 A1590 ( 4.9A)NB1 A1590 ( 3.0A) | 0.75A | 2x0yA-2j4gA:41.7 | 2x0yA-2j4gA:32.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2j4g | HYALURONOGLUCOSAMINIDASE (Bacteroidesthetaiotaomicron) |
PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 7 | LYS A 166VAL A 314TRP A 337ASN A 339VAL A 342ASP A 344ASN A 372 | NB1 A1590 (-3.0A)NoneNB1 A1590 (-3.7A)NB1 A1590 (-3.6A)NB1 A1590 ( 4.9A)NB1 A1590 ( 3.0A)NB1 A1590 (-3.4A) | 0.84A | 2x0yA-2j4gA:41.7 | 2x0yA-2j4gA:32.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2j4g | HYALURONOGLUCOSAMINIDASE (Bacteroidesthetaiotaomicron) |
PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 8 | TYR A 282THR A 310VAL A 314TRP A 337ASN A 339VAL A 342ASP A 344ASN A 372 | NB1 A1590 (-3.8A)NB1 A1590 (-3.9A)NoneNB1 A1590 (-3.7A)NB1 A1590 (-3.6A)NB1 A1590 ( 4.9A)NB1 A1590 ( 3.0A)NB1 A1590 (-3.4A) | 0.49A | 2x0yA-2j4gA:41.7 | 2x0yA-2j4gA:32.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2v5d | O-GLCNACASE NAGJ (Clostridiumperfringens) |
PF00754(F5_F8_type_C)PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 5 | LYS A 218TYR A 295ASP A 297VAL A 331TYR A 335 | None | 1.17A | 2x0yA-2v5dA:52.0 | 2x0yA-2v5dA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2v5d | O-GLCNACASE NAGJ (Clostridiumperfringens) |
PF00754(F5_F8_type_C)PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 11 | LYS A 218TYR A 295VAL A 331TYR A 335THR A 366VAL A 370TRP A 394ASN A 396VAL A 399ASP A 401ASN A 429 | None | 0.58A | 2x0yA-2v5dA:52.0 | 2x0yA-2v5dA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xhy | 6-PHOSPHO-BETA-GLUCOSIDASE BGLA (Escherichiacoli) |
PF00232(Glyco_hydro_1) | 5 | TYR A 194VAL A 200TYR A 201VAL A 214VAL A 153 | None | 1.46A | 2x0yA-2xhyA:14.5 | 2x0yA-2xhyA:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xsb | HYALURONOGLUCOSAMINIDASE (Oceanicolagranulosus) |
PF07555(NAGidase) | 8 | LYS A 39ASP A 115TYR A 160THR A 191TRP A 219ASN A 221ASP A 226ASN A 254 | GDL A1436 ( 3.8A)NoneGDL A1436 (-3.6A)GDL A1436 ( 4.5A)GDL A1436 (-3.6A)GDL A1436 (-3.0A)GDL A1436 (-3.0A)GDL A1436 (-3.4A) | 0.42A | 2x0yA-2xsbA:38.6 | 2x0yA-2xsbA:21.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z2f | LYSOZYME C-2 (Bos taurus) |
PF00062(Lys) | 5 | ASP A 117VAL A 120TRP A 111ASN A 27VAL A 23 | None | 1.28A | 2x0yA-2z2fA:undetectable | 2x0yA-2z2fA:12.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c7k | GUANINENUCLEOTIDE-BINDINGPROTEIN G(O) SUBUNITALPHA (Mus musculus) |
PF00503(G-alpha) | 5 | LYS A 51TYR A 69VAL A 72VAL A 186ASP A 201 | GDP A 361 ( 4.5A)NoneNoneNone MG A 362 ( 4.5A) | 1.41A | 2x0yA-3c7kA:3.2 | 2x0yA-3c7kA:19.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3igr | RIBOSOMAL-PROTEIN-S5-ALANINEN-ACETYLTRANSFERASE (Aliivibriofischeri) |
PF13302(Acetyltransf_3) | 5 | TYR A 86VAL A 84TYR A 101VAL A 147ASN A 118 | NoneNoneNoneNone NA A 185 (-4.4A) | 1.33A | 2x0yA-3igrA:undetectable | 2x0yA-3igrA:14.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kxw | SAFRAMYCIN MX1SYNTHETASE B (Legionellapneumophila) |
PF00501(AMP-binding) | 5 | ASP A 440VAL A 451THR A 335VAL A 334ASP A 218 | 1ZZ A 589 (-2.8A)1ZZ A 589 (-4.4A)NoneNone1ZZ A 589 (-2.5A) | 0.97A | 2x0yA-3kxwA:undetectable | 2x0yA-3kxwA:21.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nz4 | PHENYLALANINEAMMONIA-LYASE (Taxuscanadensis) |
PF00221(Lyase_aromatic) | 5 | THR A 141VAL A 29ASN A 138VAL A 349ASN A 350 | None | 1.43A | 2x0yA-3nz4A:3.0 | 2x0yA-3nz4A:22.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fhn | NUCLEOPORIN NUP120 (Schizosaccharomycespombe) |
PF11715(Nup160) | 5 | ASP B 525VAL B 530TYR B 532VAL B 88ASN B 91 | None | 1.50A | 2x0yA-4fhnB:undetectable | 2x0yA-4fhnB:19.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ksi | LEUCINEAMINOPEPTIDASE 1,CHLOROPLASTIC (Solanumlycopersicum) |
PF00883(Peptidase_M17)PF02789(Peptidase_M17_N) | 5 | ASP A 347THR A 433VAL A 310VAL A 423ASN A 514 | MG A 601 ( 2.5A)NoneNoneNoneNone | 1.31A | 2x0yA-4ksiA:2.4 | 2x0yA-4ksiA:23.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4phs | PUTATIVEGLYCOSYLTRANSFERASE(GALT1) (Streptococcusparasanguinis) |
PF08759(GT-D) | 5 | ASP A 181TYR A 180THR A 203VAL A 206ASN A 48 | None | 1.38A | 2x0yA-4phsA:undetectable | 2x0yA-4phsA:18.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yb9 | SOLUTE CARRIERFAMILY 2,FACILITATED GLUCOSETRANSPORTER MEMBER 5 (Bos taurus) |
PF00083(Sugar_tr) | 5 | VAL D 164THR D 171VAL D 326ASN D 325VAL D 384 | None | 1.46A | 2x0yA-4yb9D:2.4 | 2x0yA-4yb9D:21.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zxl | O-GLCNACASE NAGJ (Clostridiumperfringens) |
PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 6 | LYS A 218TYR A 295ASN A 396VAL A 399ASP A 401ASN A 429 | None | 0.92A | 2x0yA-4zxlA:54.3 | 2x0yA-4zxlA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zxl | O-GLCNACASE NAGJ (Clostridiumperfringens) |
PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 10 | TYR A 295ASP A 297VAL A 331TYR A 335THR A 366VAL A 370ASN A 396VAL A 399ASP A 401ASN A 429 | None | 0.61A | 2x0yA-4zxlA:54.3 | 2x0yA-4zxlA:99.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4zxl | O-GLCNACASE NAGJ (Clostridiumperfringens) |
PF02838(Glyco_hydro_20b)PF07555(NAGidase) | 10 | TYR A 295VAL A 331TYR A 335THR A 366VAL A 370TRP A 394ASN A 396VAL A 399ASP A 401ASN A 429 | None | 0.48A | 2x0yA-4zxlA:54.3 | 2x0yA-4zxlA:99.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5diy | HYALURONIDASE (Thermobaculumterrenum) |
PF07555(NAGidase) | 8 | ASP A 119TYR A 168THR A 193VAL A 197ASN A 223VAL A 226ASP A 228ASN A 257 | None | 0.63A | 2x0yA-5diyA:41.7 | 2x0yA-5diyA:24.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5diy | HYALURONIDASE (Thermobaculumterrenum) |
PF07555(NAGidase) | 8 | TYR A 168THR A 193VAL A 197TRP A 221ASN A 223VAL A 226ASP A 228ASN A 257 | None | 0.47A | 2x0yA-5diyA:41.7 | 2x0yA-5diyA:24.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gjw | VOLTAGE-DEPENDENTCALCIUM CHANNELSUBUNITALPHA-2/DELTA-1 (Oryctolaguscuniculus) |
PF00092(VWA)PF08399(VWA_N)PF08473(VGCC_alpha2) | 5 | ASP F 454VAL F 461TYR F 452THR F 449VAL F 489 | None | 1.24A | 2x0yA-5gjwF:undetectable | 2x0yA-5gjwF:19.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5gzs | GGDEF FAMILY PROTEIN (Vibrio cholerae) |
PF00497(SBP_bac_3) | 5 | TYR A 148ASP A 184VAL A 183TYR A 127ASN A 203 | ARG A 501 (-4.1A)ARG A 501 ( 4.9A)NoneNoneNone | 1.43A | 2x0yA-5gzsA:undetectable | 2x0yA-5gzsA:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m7r | PROTEIN O-GLCNACASE (Homo sapiens) |
PF07555(NAGidase) | 6 | ASP A 174TYR A 219THR A 250VAL A 254ASN A 280ASP A 285 | None | 0.81A | 2x0yA-5m7rA:39.0 | 2x0yA-5m7rA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5m7r | PROTEIN O-GLCNACASE (Homo sapiens) |
PF07555(NAGidase) | 7 | TYR A 219THR A 250VAL A 254TRP A 278ASN A 280ASP A 285ASN A 313 | None | 0.46A | 2x0yA-5m7rA:39.0 | 2x0yA-5m7rA:22.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uhk | O-GLCNACASETIM-BARREL DOMAIN (Homo sapiens) |
PF07555(NAGidase) | 9 | LYS A 98ASP A 174TYR A 219THR A 250VAL A 254TRP A 278ASN A 280ASP A 285ASN A 313 | GOL A 502 (-4.0A)GOL A 501 (-3.1A)GOL A 501 (-3.3A)GOL A 501 (-4.4A)NoneGOL A 501 (-3.6A)GOL A 501 (-3.4A)GOL A 502 (-2.9A)GOL A 502 (-3.4A) | 0.73A | 2x0yA-5uhkA:37.4 | 2x0yA-5uhkA:24.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uhp | O-GLCNACASETIM-BARREL DOMAIN (Homo sapiens) |
PF07555(NAGidase) | 8 | ASP A 174TYR A 219THR A 250VAL A 254TRP A 278ASN A 280ASP A 285ASN A 313 | GOL A 501 (-2.5A)GOL A 501 (-3.7A)GOL A 501 (-4.2A)GOL A 501 (-4.2A)GOL A 501 (-3.8A)GOL A 501 (-3.4A)NoneNone | 0.54A | 2x0yA-5uhpA:36.5 | 2x0yA-5uhpA:29.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vvo | PROTEIN O-GLCNACASE (Homo sapiens) |
PF07555(NAGidase) | 6 | ASP A 174TYR A 219VAL A 254ASN A 280ASP A 285ASN A 313 | None | 0.79A | 2x0yA-5vvoA:38.7 | 2x0yA-5vvoA:25.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vvo | PROTEIN O-GLCNACASE (Homo sapiens) |
PF07555(NAGidase) | 7 | TYR A 219THR A 250VAL A 254TRP A 278ASN A 280ASP A 285ASN A 313 | None | 0.40A | 2x0yA-5vvoA:38.7 | 2x0yA-5vvoA:25.73 |